2-Methyl-3(2-furyl)acrolein
Common Name: |
2-Methyl-3(2-furyl)acrolein |
IUPAC Name: |
(Z)-3-(furan-2-yl)-2-methylprop-2-enal |
Molecular Formula: |
C8H8O2 |
SMILES: |
CC(=CC1=CC=CO1)C=O |
Inchi: |
1S/C8H8O2/c1-7(6-9)5-8-3-2-4-10-8/h2-6H,1H3/b7-5- |
Inchi Key: |
ZNBXZUKDRRRQJK-ALCCZGGFSA-N |
Cas No: |
874-66-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
136.15 |
Mass (g/mol) |
136.052 |
Molar Refractivity |
38.61 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
30.21 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
110.00 @ 2.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.113 |
Vapor Density (Air =1) |
4.6 |
Fraction Csp3 |
0.12 |
LogP |
1.882 |
iLOGP |
1.68 |
XLOGP3 |
1.59 |
WLOGP |
1.77 |
MLOGP |
0.42 |
ESOL Log S |
-1.92 |
ESOL Solubility (mg/ml) |
1.62 |
ESOL Solubility (mol/l) |
0.012 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.84 |
Ali Solubility (mg/ml) |
1.99 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.00 |
Silicos-IT Solubility (mg/ml) |
1.35 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.00 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.607 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.782 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |